Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept.

Lisbona MP, Maymó J, Perich J, Almirall M, Carbonell J.

Ann Rheum Dis. 2010 Jun;69(6):1117-22. doi: 10.1136/ard.2009.116277. Epub 2010 May 6.

PMID:
20448287
2.

Etanercept reduces synovitis as measured by magnetic resonance imaging in patients with active rheumatoid arthritis after only 6 weeks.

Lisbona MP, Maymo J, Perich J, Almirall M, Pérez-García C, Carbonell J.

J Rheumatol. 2008 Mar;35(3):394-7. Epub 2008 Jan 15.

PMID:
18203329
3.

The synthesis of phosphopeptides via the Bpoc-based approach.

Attard TJ, Reynolds EC, Perich JW.

Org Biomol Chem. 2007 Feb 21;5(4):664-70. Epub 2007 Jan 12.

PMID:
17285175
4.

Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.

Catafau AM, Perez V, Plaza P, Pascual JC, Bullich S, Suarez M, Penengo MM, Corripio I, Puigdemont D, Danus M, Perich J, Alvarez E.

Psychopharmacology (Berl). 2006 Dec;189(2):145-53. Epub 2006 Oct 11.

PMID:
17033844
5.

Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.

Catafau AM, Danus M, Bullich S, Llop J, Perich J, Cunningham VJ, Plaza P, Penengo MM, Eersels JL, Squassante L, Ros D, Barbanoj M.

J Nucl Med. 2006 Jun;47(6):919-28.

6.

[Pulmonary abscess and cerebral abscesses in immunocompetent patient].

Payès M, Mercadal J, Knobel H, Zamora V, Vall-Llossera A, García G, Perich J.

Rev Clin Esp. 2005 Oct;205(10):511-2. Spanish. No abstract available.

PMID:
16238965
7.

SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.

Catafau AM, Pérez V, Penengo MM, Bullich S, Danús M, Puigdemont D, Pascual JC, Corripio I, Llop J, Perich J, Alvarez E.

J Nucl Med. 2005 Aug;46(8):1301-9.

8.

Physicochemical characterization of casein phosphopeptide-amorphous calcium phosphate nanocomplexes.

Cross KJ, Huq NL, Palamara JE, Perich JW, Reynolds EC.

J Biol Chem. 2005 Apr 15;280(15):15362-9. Epub 2005 Jan 17.

10.

N-terminal sequence analysis of bovine dentin phosphophoryn after conversion of phosphoseryl to S-propylcysteinyl residues.

Huq NL, Cross KJ, Talbo GH, Riley PF, Loganathan A, Crossley MA, Perich JW, Reynolds EC.

J Dent Res. 2000 Nov;79(11):1914-9.

PMID:
11145365
11.

Epitope analysis of the multiphosphorylated peptide alpha s1-casein (59-79).

Perich JW, Black CL, Huq NL, Reynolds EC.

J Pept Sci. 1999 May;5(5):221-33.

PMID:
10363905
12.
13.

Synthesis of phosphopeptides using modern chemical approaches.

Perich JW.

Methods Enzymol. 1997;289:245-66. Review. No abstract available.

PMID:
9353725
14.
16.

Anticariogenicity of calcium phosphate complexes of tryptic casein phosphopeptides in the rat.

Reynolds EC, Cain CJ, Webber FL, Black CL, Riley PF, Johnson IH, Perich JW.

J Dent Res. 1995 Jun;74(6):1272-9.

PMID:
7629336
17.

Further studies into the Boc/solid-phase synthesis of Ser(P)- and Thr(P)-containing peptides.

Perich JW, Terzi E, Carnazzi E, Seyer R, Trifilieff E.

Int J Pept Protein Res. 1994 Oct;44(4):305-12.

PMID:
7875931
18.
19.

Hydroxyapatite mineralization and demineralization in the presence of synthetic phosphorylated pentapeptides.

Wikiel K, Burke EM, Perich JW, Reynolds EC, Nancollas GH.

Arch Oral Biol. 1994 Aug;39(8):715-21.

PMID:
7980121
20.

Efficient Fmoc/solid-phase peptide synthesis of O-phosphotyrosyl-containing peptides and their use as phosphatase substrates.

Perich JW, Ruzzene M, Pinna LA, Reynolds EC.

Int J Pept Protein Res. 1994 Jan;43(1):39-46.

PMID:
7511131
21.

The synthesis and use of pp60src-related peptides and phosphopeptides as substrates for enzymatic phosphorylation studies.

Perich JW, Meggio F, Valerio RM, Johns RB, Pinna LA, Reynolds EC.

Bioorg Med Chem. 1993 Nov;1(5):381-8.

PMID:
7521748
22.

Strategies for nonradioactive methods in the localization of phosphorylated amino acids in proteins.

Meyer HE, Eisermann B, Heber M, Hoffmann-Posorske E, Korte H, Weigt C, Wegner A, Hutton T, Donella-Deana A, Perich JW.

FASEB J. 1993 Jun;7(9):776-82. Review.

PMID:
7687226
23.
24.

Specificity of T-cell protein tyrosine phosphatase toward phosphorylated synthetic peptides.

Ruzzene M, Donella-Deana A, Marin O, Perich JW, Ruzza P, Borin G, Calderan A, Pinna LA.

Eur J Biochem. 1993 Jan 15;211(1-2):289-95.

25.

Efficient solution-phase synthesis of multiple O-phosphoseryl-containing peptides related to casein and statherin.

Perich JW, Kelly DP, Reynolds EC.

Int J Pept Protein Res. 1992 Aug;40(2):81-8.

PMID:
1446973
27.
28.

The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme.

Meggio F, Boldyreff B, Marin O, Marchiori F, Perich JW, Issinger OG, Pinna LA.

Eur J Biochem. 1992 May 1;205(3):939-45.

29.

The comparative efficiencies of the Ser(P)-, Thr(P)- and Tyr(P)-residues as specificity determinants for casein kinase-1.

Meggio F, Perich JW, Marin O, Pinna LA.

Biochem Biophys Res Commun. 1992 Feb 14;182(3):1460-5.

PMID:
1540189
30.
31.

Fmoc/solid-phase synthesis of Tyr(P)-containing peptides through t-butyl phosphate protection.

Perich JW, Reynolds EC.

Int J Pept Protein Res. 1991 Jun;37(6):572-5.

PMID:
1717394
32.
33.

Synthesis of O-phosphoserine- and O-phosphothreonine-containing peptides.

Perich JW.

Methods Enzymol. 1991;201:225-33. No abstract available.

PMID:
1943766
34.

Synthesis of O-phosphotyrosine-containing peptides.

Perich JW.

Methods Enzymol. 1991;201:234-45.

PMID:
1719342
35.

Disseminated lymphatic tuberculosis in acquired immunodeficiency syndrome: computed tomography findings.

Perich J, Ayuso MC, Vilana R, Ayuso JR, Cardenal C, Mallofré C.

Can Assoc Radiol J. 1990 Dec;41(6):353-7.

PMID:
2257509
36.

Phosphorylation of src-phosphopeptides by casein kinases-1 and -2: favourable effect of phosphotyrosine.

Perich JW, Meggio F, Kitas EA, Valerio RM, Johns RB, Pinna LA.

Biochem Biophys Res Commun. 1990 Jul 31;170(2):635-42. Erratum in: Biochem Biophys Res Commun 1990 Sep 28;171(3):1414.

PMID:
1696474
37.

Synthetic peptides as model substrates for the study of the specificity of the polycation-stimulated protein phosphatases.

Agostinis P, Goris J, Pinna LA, Marchiori F, Perich JW, Meyer HE, Merlevede W.

Eur J Biochem. 1990 Apr 30;189(2):235-41.

38.

Synthetic fragments of beta-casein as model substrates for liver and mammary gland casein kinases.

Meggio F, Perich JW, Meyer HE, Hoffmann-Posorske E, Lennon DP, Johns RB, Pinna LA.

Eur J Biochem. 1989 Dec 22;186(3):459-64.

39.

Partially dephosphorylated phosphopeptide AcSer(P)-Ser(P)-Ser(P) is an excellent substrate for casein kinase-2.

Meggio F, Perich JW, Johns RB, Pinna LA.

FEBS Lett. 1988 Sep 12;237(1-2):225-8.

40.

[Fatal hemorrhages from delivery of the placenta in the Maternidad Provincial de Barcelona in a period of more than thirty years].

DEXEUS S, PERICH J.

Tokoginecol Pract. 1953 May;12(112):207-236. No abstract available.

PMID:
13102535
41.

[Asphyxia of the newborn].

PERICH J.

J Prat Rev Gen Clin Ther. 1950 Aug 3;64(31):374. Undetermined Language. No abstract available.

PMID:
14774806
42.

[Menstrual cycle].

PERICH J.

J Prat Rev Gen Clin Ther. 1950 Jul 13;64(28):342. Undetermined Language. No abstract available.

PMID:
15437434
43.

[Prophylaxis and treatment of puerperal infection].

PERICH J.

J Prat Rev Gen Clin Ther. 1950 Feb 23;64(8):90. Undetermined Language. No abstract available.

PMID:
15437353
44.

Purpura hémorragique chez un typhique guérison par la transfusion nédullaire.

DESMONTS T, REVERDY L, PERICH J.

Sang. 1948;19(1):61. Undetermined Language. No abstract available.

PMID:
18902589

Supplemental Content

Loading ...
Support Center